Carnosine exerts antitumor activity against bladder cancers in vitro and in vivo via suppression of angiogenesis.
暂无分享,去创建一个
Yung-Hyun Choi | Wun-Jae Kim | S. Moon | Jun-Hui Song | B. Hwang | Seung S. Shin | S. Moon
[1] G. Aldini,et al. A carnosine analog mitigates metabolic disorders of obesity by reducing carbonyl stress , 2018, The Journal of clinical investigation.
[2] Yanrong Chen,et al. Investigations on in vitro anti-carcinogenic potential of l-carnosine in liver cancer cells , 2018, Cytotechnology.
[3] S. Culine,et al. Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial , 2017, The Lancet.
[4] Chris Berdik. Unlocking bladder cancer , 2017, Nature.
[5] Yung-Hyun Choi,et al. HSP70-1 is required for interleukin-5-induced angiogenic responses through eNOS pathway , 2017, Scientific Reports.
[6] K. Trinkaus,et al. Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma. , 2016, Oral oncology.
[7] K. Książek,et al. L-Carnosine Prevents the Pro-cancerogenic Activity of Senescent Peritoneal Mesothelium Towards Ovarian Cancer Cells. , 2016, Anticancer research.
[8] J. Hainsworth,et al. A randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancer. , 2015, European journal of cancer.
[9] Jianxin Lu,et al. Carnosine Inhibits the Proliferation of Human Gastric Cancer SGC-7901 Cells through Both of the Mitochondrial Respiration and Glycolysis Pathways , 2014, PloS one.
[10] F. Gaunitz,et al. Inhibition of tumour cell growth by carnosine: some possible mechanisms , 2014, Amino Acids.
[11] G. Aldini,et al. Physiology and pathophysiology of carnosine. , 2013, Physiological reviews.
[12] T. Downs,et al. Expression Microarray Meta-Analysis Identifies Genes Associated with Ras/MAPK and Related Pathways in Progression of Muscle-Invasive Bladder Transition Cell Carcinoma , 2013, PloS one.
[13] S. Menini,et al. D‐carnosine octylester attenuates atherosclerosis and renal disease in ApoE null mice fed a Western diet through reduction of carbonyl stress and inflammation , 2012, British journal of pharmacology.
[14] M. Pricolo,et al. Carnosine inhibits KRAS-mediated HCT116 proliferation by affecting ATP and ROS production. , 2012, Cancer letters.
[15] Fa-lin Xu,et al. Carnosine pretreatment protects against hypoxia-ischemia brain damage in the neonatal rat model. , 2011, European journal of pharmacology.
[16] K. Bensalah,et al. Prognostic factors for upper urinary tract urothelial carcinoma , 2011, Nature Reviews Urology.
[17] G. Aldini,et al. Design, Synthesis, ADME Properties, and Pharmacological Activities of β‐Alanyl‐D‐histidine (D‐Carnosine) Prodrugs with Improved Bioavailability , 2011, ChemMedChem.
[18] R. Seiler,et al. MMP-2 and MMP-9 in lymph-node-positive bladder cancer , 2011, Journal of Clinical Pathology.
[19] B. Rolando,et al. Synthesis, physicochemical characterization, and biological activities of new carnosine derivatives stable in human serum as potential neuroprotective agents. , 2011, Journal of medicinal chemistry.
[20] Tianhong Li,et al. A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial , 2010, Investigational New Drugs.
[21] T. Sato,et al. Biological Activity of Novel Synthetic Derivatives of Carnosine , 2010, Cellular and Molecular Neurobiology.
[22] D. Camidge,et al. Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] Hongtao Jia,et al. Ras-MAPK pathway as a therapeutic target in cancer--emphasis on bladder cancer. , 2009, Recent patents on anti-cancer drug discovery.
[24] S. Fang,et al. Carnosine inhibits high glucose-induced mesangial cell proliferation through mediating cell cycle progression , 2009, Regulatory Peptides.
[25] G. Gillies,et al. In vitro angiogenesis by human umbilical vein endothelial cells (HUVEC) induced by three-dimensional co-culture with glioblastoma cells , 2009, Journal of Neuro-Oncology.
[26] R. Sclafani,et al. Cell cycle regulation of DNA replication. , 2007, Annual review of genetics.
[27] M. Swellam,et al. Noninvasive diagnosis of bladder cancer by detection of matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitor (TIMP-2) in urine. , 2007, European urology.
[28] J. Huot,et al. Endothelial cell migration during angiogenesis. , 2007, Circulation research.
[29] S. Lamy,et al. A prostate secretory protein94‐derived synthetic peptide PCK3145 inhibits VEGF signalling in endothelial cells: Implication in tumor angiogenesis , 2006, International journal of cancer.
[30] Cheng-chin Hsu,et al. Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation. , 2005, European Journal of Pharmacology.
[31] Napoleone Ferrara,et al. Vascular endothelial growth factor: basic science and clinical progress. , 2004, Endocrine reviews.
[32] M. Loda,et al. A Phase II Clinical and Pharmacodynamic Study of E7070 in Patients with Metastatic, Recurrent, or Refractory Squamous Cell Carcinoma of the Head and Neck , 2004, Clinical Cancer Research.
[33] C. Sawyers,et al. The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.
[34] J. Blow,et al. The origin of CDK regulation , 2001, Nature Cell Biology.
[35] N. Holbrook,et al. Requirement for ERK Activation in Cisplatin-induced Apoptosis* , 2000, The Journal of Biological Chemistry.
[36] R. Millikan,et al. The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[37] H. Haller,et al. Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. , 2000, Journal of cell science.
[38] F. André,et al. Insulin-like Growth Factor-I Protects Colon Cancer Cells from Death Factor-induced Apoptosis by Potentiating Tumor Necrosis Factor α-induced Mitogen-activated Protein Kinase and Nuclear Factor κB Signaling Pathways , 2000 .
[39] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[40] C. Marshall,et al. How do small GTPase signal transduction pathways regulate cell cycle entry? , 1999, Current opinion in cell biology.
[41] R. Busse,et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation , 1999, Nature.
[42] J. Isner,et al. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. , 1999, The Journal of clinical investigation.
[43] D. Grignon,et al. Matrix metalloproteinase-9 expression in bladder washes from bladder cancer patients predicts pathological stage and grade. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[44] Vishva Dixit,et al. Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway , 1998, The Journal of Biological Chemistry.
[45] E. Levin,et al. Extracellular Signal-regulated Protein Kinase/Jun Kinase Cross-talk Underlies Vascular Endothelial Cell Growth Factor-induced Endothelial Cell Proliferation* , 1998, The Journal of Biological Chemistry.
[46] C. Chi,et al. Submicromolar paclitaxel induces apoptosis in human gastric cancer cells at early G1 phase. , 1998, Anticancer research.
[47] A. Hipkiss,et al. Toxic effects of β-amyloid(25–35) on immortalised rat brain endothelial cell: protection by carnosine, homocarnosine and β-alanine , 1998, Neuroscience Letters.
[48] A. Harris,et al. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer. , 1997, Cancer research.
[49] A. Mantovani,et al. Molecular mechanisms of blood vessel formation. , 1997, Trends in biochemical sciences.
[50] D. Hanahan,et al. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.
[51] P. Carroll,et al. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. , 1995, The Journal of urology.
[52] A. Harris,et al. Different angiogenic pathways characterize superficial and invasive bladder cancer. , 1995, Cancer research.
[53] A. Hanby,et al. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. , 1993, Cancer research.
[54] J. Richie,et al. Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. , 1993, Journal of the National Cancer Institute.
[55] C. Osborne,et al. Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. , 1983, Cancer research.
[56] A. Jemal,et al. Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.
[57] C. Barrios,et al. Boldine induces cell cycle arrest and apoptosis in T24 human bladder cancer cell line via regulation of ERK, AKT, and GSK-3β. , 2014, Urologic oncology.
[58] P. Jakeman,et al. Carnosine and anserine concentrations in the quadriceps femoris muscle of healthy humans , 2004, European Journal of Applied Physiology and Occupational Physiology.
[59] D. Ito,et al. Effect of 5-fluorouracil on G1 phase cell cycle regulation in oral cancer cell lines. , 2004, Oral oncology.
[60] N. G. Davydova,et al. Efficacy of N-Acetylcarnosine in the Treatment of Cataracts , 2002, Drugs in R&D.
[61] F. André,et al. Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways. , 2000, Cancer research.
[62] T. Suda,et al. [Antineoplastic effects of carnosine and beta-alanine--physiological considerations of its antineoplastic effects]. , 1986, Nihon seirigaku zasshi. Journal of the Physiological Society of Japan.